Alexza Pharmaceuticals, Inc. (ALXA) Tops Q1 EPS by 4c

May 10, 2012 4:39 PM EDT
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) reported Q1 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $1.88 million versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Alexza Pharmaceuticals, Inc. (ALXA) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings